Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.
Overview
Exciting new "biologic" therapies for treating leukemia are appearing so rapidly that clinicians often find it difficult to make informed decisions about their use when making patient treatment decisions. Biologic Therapy of Leukemia summarizes and reviews all the available data concerning these cutting-edge biologic therapies so that practicing clinicians can make the correct patient-care choices. Here the busy physician will find in one convenient place crucial information on the uses and limitations of the major biologic therapies for leukemia, the different biologic strategies for its treatment, the management of patients being treated with such biologic agents, and the current and future role of emerging biologic agents.
Synopsis
Kalaycio has edited 14 articles that detail current research and method in the areas of immunotherapy, cytokines, targeted therapeutics, differentiation agents, and gene therapy used in the treatment of leukemia. Individual topics include graft vs. leukemia effect, unconjugated monoclonal antibodies, interferons, interleukin-2 treatment of acute leukemia, antisense therapy, signal transduction inhibitors, p-glycoprotein inhibition in acute myeloid leukemia, and arsenicals. The contributors, who practice mainly in the US (four are in France, Germany, and Singapore), provide a full list of references at the conclusion of each chapter. Annotation ©2003 Book News, Inc., Portland, OR